Ireland · Delayed Price · Currency is EUR Kerry Group Earnings Call Transcripts
Fiscal Year 2026
-
Focused on high single-digit earnings growth, the company leverages innovation, biotechnology, and digital transformation to outperform dynamic food and beverage markets. Strong financial performance, margin expansion, and disciplined capital allocation underpin continued growth and market leadership.
Fiscal Year 2025
-
Delivered strong volume and margin growth in 2025, with robust innovation and strategic investments driving outperformance across regions. Outlook for 2026 includes continued margin expansion, high single-digit EPS growth, and further digital and operational efficiencies.
-
Delivered 3% volume growth and strong EBITDA margin expansion, outperforming end markets. Full-year guidance for adjusted EPS and volume growth reiterated, with robust innovation in food service and private label, and continued investment in biotechnology and digital transformation.
-
Strong H1 results with 3% volume growth and 100 bps EBITDA margin expansion, outpacing flat end markets. Full-year EPS guidance is maintained, with margin outlook raised and volume growth moderated to 3% amid continued innovation and robust cash generation.
-
Q1 2025 saw 3.1% volume growth and 6.3% revenue growth, with strong margin expansion and innovation-led gains in Americas and APMEA, while Europe remained flat. Full-year guidance for 7-11% EPS growth is maintained, with a new EUR 300 million share buyback announced.
-
The company has transformed into a focused taste and nutrition leader, leveraging innovation and sustainability to drive growth. Strong financial performance, robust partnerships, and targeted capital allocation underpin ambitious margin and EPS growth targets through 2028.
Fiscal Year 2024
-
Delivered strong 2024 results with 3.3% volume growth, 120 bps EBITDA margin expansion, and robust cash generation. Outlook for 2025 targets continued outperformance, margin growth, and high single-digit EPS growth, supported by operational efficiencies and innovation.
-
A €500 million sale of Kerry Dairy Ireland will transform the group into a pure-play B2B taste and nutrition company, boosting EBITDA margins, volume growth, and sustainability metrics, with minimal EPS dilution and improved cash flow conversion. Shareholder approval is required, and the transaction is set to close by January 2025.
-
Q3 saw strong volume growth and margin expansion, led by Foodservice and robust Americas performance. Full-year guidance for 7%-10% adjusted EPS growth is maintained, with continued focus on innovation, capital flexibility, and market penetration opportunities.
-
Positioned for above-market growth, leveraging a diversified portfolio, strong innovation in taste and biotechnology, and a focus on sustainability. Margin expansion to 19-20% is targeted by 2026, with robust cash generation and disciplined capital allocation supporting continued investment and returns.
-
Strong H1 2024 results with 3.1% T&N volume growth, 6.6% EBITDA increase, and upgraded EPS guidance to 7%-10% growth. Margin expansion, robust cash flow, and strategic investments, including acquisitions and share buybacks, support continued outperformance in key markets.